A phase 1, randomized, double-blind, placebo-controlled dose-escalating, safety, tolerability, pharmacokinetic, and pharmacodynamic study of oral recombinant human interleukin eleven (O-rhIl-11) in normal healthy subjects

✍ Scribed by Cotreau, Monette M.; Stonis, Lucille; Schwertschlag, Ullrich S.

• Book ID: 123321801
• Publisher: Elsevier Science
• Year: 2003
• Tongue: English
• Weight: 170 KB
• Volume: 124
• Category: Article
• ISSN: 0016-5085
• DOI: 10.1016/S0016-5085(03)81907-8